PATENT CLAIM ANALYSIS

Application Number: 15743836
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-10
Patent Classification: ["536", "023100"]

Abstract:
The present disclosure relates to a biomarker for diagnosis of drug addiction and a kit for diagnosis of drug addiction. The biomarker for diagnosis of drug addiction and the kit for diagnosis of drug addiction according to the present disclosure can determine drug addiction by using a molecular biological method. Especially, the present disclosure has investigated molecular biologically how microRNA functions in the human brain due to drug addiction and how the microRNA is transferred to blood or serum by using an exosome as a means of transport. Therefore, the problem that, even though the change in the expression pattern of the microRNA in the brain is validated, it is difficult to apply the change in the expression pattern in the brain for clinical purposes directly and simply, was solved.

Claim (Index 3):
A kit for diagnosis of drug addiction, comprising microRNA-137 represented by SEQ ID NO 1 or its complementary base sequence represented by SEQ ID NO 2, a fragment thereof, a primer or a probe binding specifically thereto, or an antibody binding specifically to a protein encoded thereby.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 2.17188
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15390301', '15456039', '15178138', '09776117', '09933157']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5696613906235395
- 35 USC 102 Novelty (BERT): 0.4968814154662669
- Combined Prediction Score: 0.5623833931078123
- Mean Citation Score: 158.20391800000004
- Max Citation Score: 160.08757
- Similarity Product: 89.1370464867878

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test